| VF group | Non-VF group | p-value |
---|---|---|---|
Number | 104 | 175 | Â |
Age (years) (mean ± SD) | 79.9 ± 7.7 | 76.0 ± 8.2 | < 0.001 |
Female sex (n, %) | 75 (72.1%) | 120 (68.6%) | 0.59 |
Height (cm) (mean ± SD) | 151.4 ± 10.1 | 153.9 ± 7.8 | 0.03 |
Weight (kg) (mean ± SD) | 50.9 ± 11.2 | 55.8 ± 10.3 | < 0.001 |
BMI (kg/m2) (mean ± SD) | 22.0 ± 3.4 | 23.5 ± 3.8 | 0.003 |
Type 2 DM (n, %) | 12 (11.5%) | 23 (13.1%) | 0.85 |
Rheumatoid arthritis (n, %) | 14 (13.5%) | 19 (10.9%) | 0.57 |
Steroid use (n, %) | 9 (8.7%) | 10 (5.7%) | 0.46 |
TBS (L2–4) (mean ± SD) | 1.28 ± 0.11 | 1.35 ± 0.09 | < 0.001 |
 High (≥ 1.31) (n, %) | 36 (32.4) | 112 (64) | < 0.001 |
 Intermediate (1.23–1.31) (n, %) | 34 (32.4) | 53 (30.3) | 0.69 |
 Low (≤ 1.23) (n, %) | 34 (34.3) | 10 (5.7) | < 0.001 |
BMD (lumbar spine) (g/cm2) (mean ± SD) | 0.76 ± 0.17 | 0.92 ± 0.20 | < 0.001 |
T-score (lumbar spine) (mean ± SD) | −2 ± 1.4 | −0.6 ± 1.8 | < 0.001 |
 Normal (n, %) | 20 (19.2) | 96 (54.9) | < 0.001 |
 Osteopenia (n, %) | 39 (37.1) | 54 (30.9) | 0.29 |
 Osteoporosis (n, %) | 45 (42.9) | 25 (14.3) | < 0.001 |
BMD (femoral neck) (g/cm2) (mean ± SD) | 0.51 ± 0.13 | 0.60 ± 0.13 | < 0.001 |
T-score (femoral neck) (mean ± SD) | −3.2 ± 1.4 | −2.2 ± 1.5 | < 0.001 |
 Normal (n, %) | 5 (5.1) | 28 (16.1) | < 0.001 |
 Osteopenia (n, %) | 22 (22.4) | 64 (36.8) | 0.02 |
 Osteoporosis (n, %) | 71 (72.5) | 82 (47.1) | < 0.001 |